The Dual Function of RhoGDI2 in Immunity and Cancer

被引：3
|
作者：
Tripathi, Mudrika [1 ]
Colige, Alain [1 ]
Deroanne, Christophe F. F. [1 ]
机构：
[1] Univ Liege, Lab Connect Tissues Biol, GIGA Canc, B-4000 Liege, Belgium
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 04期
关键词：
RhoGDI2; 1; RhoGDI1; 2; Rho GTPases 3; cancer; 4; immunity; 5; GDP-DISSOCIATION INHIBITOR; LY-GDI; RHO-GTPASES; CELL-PROLIFERATION; BREAST-CANCER; EXPRESSION; INVASION; PROMOTES; MIGRATION; PROTEIN;
D O I：
10.3390/ijms24044015
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific for the Rho family of small GTPases. It is highly expressed in hematopoietic cells but is also present in a large array of other cell types. RhoGDI2 has been implicated in multiple human cancers and immunity regulation, where it can display a dual role. Despite its involvement in various biological processes, we still do not have a clear understanding of its mechanistic functions. This review sheds a light on the dual opposite role of RhoGDI2 in cancer, highlights its underappreciated role in immunity and proposes ways to explain its intricate regulatory functions.
引用
收藏
页数：19
相关论文
共 50 条
  • [41] NMR characterization of weak interactions between RhoGDI2 and fragment screening hits
    Liu, Jiuyang
    Gao, Jia
    Li, Fudong
    Ma, Rongsheng
    Wei, Qingtao
    Wang, Aidong
    Wu, Jihui
    Ruan, Ke
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (01): : 3061 - 3070
  • [42] Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma
    Yi, Bin
    Hu, You
    Qin, Gongzhao
    Gu, Wen
    Zhu, Xinguo
    He, Songbing
    Zhou, Jian
    Li, Dechun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 (01) : 205 - 212
  • [43] Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma
    Xianzheng Li
    Jianmei Wang
    Xiaojing Zhang
    Yuanfeng Zeng
    Li Liang
    Yanqing Ding
    Annals of Surgical Oncology, 2012, 19 : 145 - 153
  • [44] Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia
    Wu, Y.
    McRoberts, K.
    Berr, S. S.
    Frierson, H. F., Jr.
    Conaway, M.
    Theodorescu, D.
    ONCOGENE, 2007, 26 (05) : 765 - 773
  • [45] Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia
    Y Wu
    K McRoberts
    S S Berr
    H F Frierson
    M Conaway
    D Theodorescu
    Oncogene, 2007, 26 : 765 - 773
  • [46] RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression
    Cho, Hee Jun
    Baek, Kyoung Eun
    Park, Sun-Mi
    Kim, In-Kyu
    Nam, In-Koo
    Choi, Yeong-Lim
    Park, Seung-Ho
    Im, Min-Ju
    Choi, Jungil
    Ryu, Jinhyun
    Kim, Jae Won
    Lee, Chang Won
    Kang, Sang Soo
    Yoo, Jiyun
    CANCER LETTERS, 2011, 311 (01) : 48 - 56
  • [47] 一种高效抑制Jurkat细胞表达RhoGDI2的方法
    卫丹
    落继先
    生物技术通讯, 2016, 27 (04) : 516 - 519
  • [48] RhoGDI2 Is Expressed in Human Trophoblasts and Involved in Their Migration by Inhibiting the Activation of RAC1
    Liu, Sishi
    Cui, Hong
    Li, Qiuling
    Zhang, Lijuan
    Na, Quan
    Liu, Caixia
    BIOLOGY OF REPRODUCTION, 2014, 90 (04)
  • [49] RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells
    Zheng, Zhong
    Liu, Bingya
    Wu, Xiaohua
    CANCER CELL INTERNATIONAL, 2015, 15
  • [50] CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2
    Nagar, Harsha
    Kim, Seonhee
    Lee, Ikjun
    Choi, Su-Jeong
    Piao, Shuyu
    Jeon, Byeong Hwa
    Shong, Minho
    Kim, Cuk-Seong
    PLOS ONE, 2021, 16 (08):
12345